Explore CD314/NKG2D/KLRK1 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. This gene encodes a member of the NKG2 family. The encoded transmembrane protein is characterized by a type II membrane orientation (has an extracellular C terminus) and the presence of a C-type lectin domain. It binds to a diverse family of ligands that include MHC class I chain-related A and B proteins and UL-16 binding proteins, where ligand-receptor interactions can result in the activation of NK and T cells. The surface expression of these ligands is important for the recognition of stressed cells by the immune system, and thus this protein and its ligands are therapeutic targets for the treatment of immune diseases and cancers. Read-through transcription exists between this gene and the upstream KLRC4 (killer cell lectin-like receptor subfamily C, member 4) family member in the same cluster. [provided by RefSeq, Dec 2010]
Target ID |
GM-T35289
|
Target Name |
CD314/NKG2D/KLRK1
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
22914
|
Gene ID |
100053963 (Equus caballus), 22914 (Homo sapiens), 24934 (Rattus norvegicus), 27007 (Mus musculus) 404058 (Bos taurus), 611355 (Canis lupus familiaris)
|
Target Alternative Names |
KLRK1,Klrk1,KLR,CD314,NKG2D,NKG2-D,D12S2489E,Nkrp2,Nkg2d,D6H12S2489E,KLRC
|
Uniprot Accession |
P26718,O70215,O54709
|
Uniprot Entry Name |
|
Protein Sub-location |
Transmembrane Protein
|
Category |
Therapeutics Target, Immuno-oncology Target, INN Index
|
Disease |
cancer
|
Disease from KEGG |
Natural killer cell mediated cytotoxicity, Malaria
|
Gene Ensembl |
ENSECAG00000017267, ENSG00000213809, ENSMUSG00000030149, ENSBTAG00000004917, ENSCAFG00845026278
|
Target Classification |
Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA)
|
Pre-made viral vector of CD314/NKG2D/KLRK1 cDNA Clones/ORF Plasmid
CD314/NKG2D/KLRK1 siRNA/miRNA/oligo for RNA interfence (RNAi)
Cat No. | Product Name | GeneID | Species | Grade | Detail |
---|
pGMoligo22914 | Pre-made Human KLRK1/KLR/CD314 siRNA oligo Duplex | 22914 | Human | In-vitro grade; in-vivo grade | Detail |
pGMoligo24934 | Pre-made Rat Klrk1/NKG2D/Nkrp2 siRNA oligo Duplex | 24934 | Rat | In-vitro grade; in-vivo grade | Detail |
pGMoligo27007 | Pre-made Mouse Klrk1/Nkg2d/NKG2-D siRNA oligo Duplex | 27007 | Mouse | In-vitro grade; in-vivo grade | Detail |
pGMoligo611355 | Pre-made Dog/Canine KLRK1 siRNA oligo Duplex | 611355 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
pGMoligo404058 | Pre-made Bovines/Cattle KLRK1/KLRC/NKG2-D siRNA oligo Duplex | 404058 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
pGMoligo100053963 | Pre-made Equine/Horse KLRK1 siRNA oligo Duplex | 100053963 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CD314/NKG2D/KLRK1 antibody/GMab
Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
---|
GM-Tg-hg-T35289-Ab | Human | Anti-Human CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-rg-T35289-Ab | Rat | Anti-Rat CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-mg-T35289-Ab | Mouse | Anti-Mouse CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-cang-T35289-Ab | Dog/Canine | Anti-Dog/Canine CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-bovg-T35289-Ab | Bovines/Cattle | Anti-Bovines/Cattle CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-equg-T35289-Ab | Equine/Horse | Anti-Equine/Horse CD314/NKG2D/KLRK1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CD314/NKG2D/KLRK1 VLP (virus-like particle)
Cat No. | Species | Antigen Name | Expression Platform | Detail |
---|
GM-Tg-hg-T35289-Ag | Human | Human CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-rg-T35289-Ag | Rat | Rat CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-mg-T35289-Ag | Mouse | Mouse CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-cang-T35289-Ag | Dog/Canine | Dog/Canine CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-bovg-T35289-Ag | Bovines/Cattle | Bovines/Cattle CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-equg-T35289-Ag | Equine/Horse | Equine/Horse CD314/NKG2D/KLRK1 VLP (virus-like particle) | HEK293 | Products Developing |